Inhibition of phospholipase A(2) as a therapeutic target (Q34083811)

30 July 2017

1 reference

title

Inhibition of phospholipase A(2) as a therapeutic target (English)

1 reference

30 July 2017

S Yedgar

1 reference

30 July 2017

D Lichtenberg

series ordinal

1 reference

30 July 2017

E Schnitzer

series ordinal

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Biochimica et Biophysica Acta

30 July 2017

published in

1 reference

30 July 2017

volume

1488

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

182-187

1 reference

The growing phospholipase A2 superfamily of signal transduction enzymes

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Different functional aspects of the group II subfamily (Types IIA and V) and type X secretory phospholipase A(2)s in regulating arachidonic acid release and prostaglandin generation. Implications of cyclooxygenase-2 induction and phospholipid scramb

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Properties and regulation of cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

cPLA2 is phosphorylated and activated by MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Function and inhibition of intracellular calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Identification and characterization of human myocardial phospholipase A2 from transplant recipients suffering from end-stage ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in beta-cell cytosolic calcium ion concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Ca2+ influx, phosphoinositide hydrolysis, and histamine release induced by lysophosphatidylserine in mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Phospholipase A2: function and pharmacological regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Platelet-activating factor: the biosynthetic and catabolic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

H2O2 renders cells accessible to lysis by exogenous phospholipase A2: a novel mechanism for cell damage in inflammatory processes

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Diethyldithiocarbamate and Nitric Oxide Synergize with Oxidants and with Membrane-Damaging Agents to Injure Mammalian Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Incorporation and effect of arachidonic acid on the growth of the human K562 cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Brain phospholipase A2 is activated after experimental closed head injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Eicosanoids and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Selective COX-2 inhibitors: are they safe for the stomach?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Inhibition of eicosanoid synthesis and potential therapeutic benefits of 'dual pathway inhibition'.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Mechanism of action of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Role of prostaglandins in gastroduodenal mucosal protection.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Gastrointestinal effects of nonsteroidal anti-inflammatory therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Role and regulation of cyclooxygenase-2 during inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Selective inhibitors of cyclooxygenase-2: are they really effective, selective, and GI-safe?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Lipid mediators in inflammatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Inhibition of phospholipase

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Polyunsaturated fatty acids potentiate interleukin-1-stimulated arachidonic acid release by cells overexpressing type IIA secretory phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Phosphorylation of cytosolic group IV phospholipase A(2) is necessary but not sufficient for Arachidonic acid release in P388D(1) macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Group V phospholipase A(2)-mediated oleic acid mobilization in lipopolysaccharide-stimulated P388D(1) macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

A heparin-sensitive phospholipase A2 and prostaglandin endoperoxide synthase-2 are functionally linked in the delayed phase of prostaglandin D2 generation in mouse bone marrow-derived mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Secretory Phospholipase A2 Activates the Cascade of Mitogen-activated Protein Kinases and Cytosolic Phospholipase A2 in the Human Astrocytoma Cell Line 1321N1

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

5-Lipoxygenase Products Modulate the Activity of the 85-kDa Phospholipase A2 in Human Neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Secretory phospholipase A2 induces phospholipase Cgamma-1 activation and Ca2+ mobilization in the human astrocytoma cell line 1321N1 by a mechanism independent of its catalytic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Regulation and inhibition of phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Structure-based design of a new class of anti-inflammatory drugs: secretory phospholipase A(2) inhibitors, SPI.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Inhibition of type I and type II phospholipase A2 by phosphatidyl-ethanolamine linked to polymeric carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Interaction of hyaluronic acid-linked phosphatidylethanolamine (HyPE) with LDL and its effect on the susceptibility of LDL lipids to oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

Abatement of bleomycin-induced pulmonary injury by cell-impermeable inhibitor of phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900120-7

7 January 2021

10.1016/S1388-1981(00)00120-7

Identifiers

DOI

1 reference

release_3exdgqobzjflhfpfk523sgp5wy

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3exdgqobzjflhfpfk523sgp5wy

24 November 2022

mapped directly with Wikidata item

1 reference